CIK: 0001725722
Total reported value
$143.5M
Reporting period: 2022-09-30 · Number of holdings: 4
AH Equity Partners Bio II, L.L.C. disclosed 4 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $143.5M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "A"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Eqrx INC | Stock-Other | 60.15% | — | — | |
| 2 | NAUT | Nautilus Biotechnology INC | Stock-Other | 24.08% | — | — | |
| 3 | ERAS | Erasca INC | Stock-Other | 13.59% | — | — | |
| 4 | NVTA1EUR | Invitae CORP | Stock-Other | 2.19% | — | +9.09% |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002039349
Total reported value
$143.6M
16 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0002019411
Total reported value
$143.4M
50 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0002053960
Total reported value
$143.4M
51 stks
2025-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001829384
Total reported value
$95.6M
4 stks
2023-09-30
Stale — no recent filing
3 of the top 5 holdings overlap
CIK 0001018724
Total reported value
$2.6B
5 stks
2026-03-31
1 of the top 5 holdings overlap, including Nautilus Biotechnology INC
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Erasca INC